Related Experiment Videos
Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients
Abstract:
Platelet monoamine oxidase (MAO) and plasma amine oxidase (PAO) activities were determined in 70 normal controls and 76 psychiatric patients. Platelet MAO activity did not differ between the normal controls and patients diagnosed as schizophrenic or primary affective illness, although there was a strong trend for chronic schizophrenics to have lower MAO activity. Schizophrenic patients with Schneiderian-type hallucinatiions had significantly lower MAO activity than normal controls or schizophrenic patients who did not hallucinate. There was no relationship between hallucinations and platelet MAO activity in patients with affective psychoses. Paranoid schizophrenics did not have significantly different MAO activity from nonparanoid schizophrenics. PAO activity was generally lower in all diagnostic groups than in normal controls, but the results were statistically significant only for acute schizophrenics.
Insights
Platelet monoamine oxidase (MAO) activity was lower in schizophrenic patients with hallucinations. Plasma amine oxidase (PAO) activity was generally reduced in psychiatric patients compared to controls.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Monoamine oxidase (MAO) and plasma amine oxidase (PAO) are enzymes involved in neurotransmitter metabolism.
- Altered enzyme activity has been implicated in various psychiatric disorders.
- Platelet MAO and plasma PAO are accessible biomarkers for studying these alterations.
Purpose of the Study:
- To investigate platelet monoamine oxidase (MAO) and plasma amine oxidase (PAO) activities in psychiatric patients.
- To determine if enzyme activity correlates with specific psychiatric diagnoses and symptoms, such as hallucinations.
Main Methods:
- Enzyme activity assays were performed on platelets and plasma samples.
- Participants included 70 healthy controls and 76 psychiatric patients across different diagnostic groups.
- Statistical analyses compared enzyme activities between controls and patient groups, and among patient subgroups.
Main Results:
- Platelet MAO activity showed no significant difference in schizophrenic or primary affective illness patients compared to controls.
- A trend towards lower platelet MAO activity was observed in chronic schizophrenics.
- Schizophrenic patients experiencing Schneiderian-type hallucinations exhibited significantly lower platelet MAO activity.
- Plasma PAO activity was generally lower in most patient groups, with statistical significance noted in acute schizophrenics.
Conclusions:
- Platelet MAO activity may be reduced in schizophrenic patients with hallucinations.
- Plasma PAO activity might be altered in acute schizophrenia.
- These findings suggest potential roles for MAO and PAO in specific psychiatric conditions and symptoms.